Fund HoldingsAvidity Partners Management LP

Total Portfolio Value
$624.44M
Total Bought
$121.38M
Total Sold
$40.46M
Net Transaction
+$80.92M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
ORUKA THERAPEUTICS INC(ORKA)760,424760,424037,29972,37011.59%+35,071
DIANTHUS THERAPEUTICS INC(DNTH)2,104,1842,104,1840176,583205,11632.85%+28,533
JADE BIOSCIENCES INC1,400,7081,700,708+300,00019,68037,7906.05%+18,110
ENLIVEN THERAPEUTICS INC400,000550,000+150,00015,68027,9134.47%+12,233
CG ONCOLOGY INC(CGON)1,288,9481,398,948+110,00087,23699,39515.92%+12,159
MOBIA MED INC0798,282+798,282010,6971.71%+10,697
IMMUNIC INC(IMUX)0669,941+669,941010,2971.65%+10,297
SENSEONICS HLDGS INC(SENS)01,600,000+1,600,00009,0881.46%+9,088
AKTIS ONCOLOGY INC(AKTS)468,566484,200+15,6348,38315,6062.50%+7,223
KARYOPHARM THERAPEUTICS INC(KPTI)463,741924,487+460,7462,5839,0321.45%+6,449
TEMPUS AI INC(TEM)25,000105,000+80,0001,1316,0830.97%+4,952
STRUCTURE THERAPEUTICS INC30,00098,000+68,0001,4465,2600.84%+3,814
NUVECTIS PHARMA INC(NVCT)0200,000+200,00003,6780.59%+3,678
INSULET CORP(PODD)024,000+24,00003,6540.59%+3,654
ALAMAR BIOSCIENCES INC0110,000+110,00002,9800.48%+2,980
CHARLES RIV LABS INTL INC(CRL)010,000+10,00002,2680.36%+2,268
AVALYN PHARMACEUTICALS INC060,000+60,00001,9750.32%+1,975
PALVELLA THERAPEUTICS INC NE(PVLA)70,00070,00008,72610,6971.71%+1,972
KAILERA THERAPEUTICS INC080,000+80,00001,7620.28%+1,762
REPLIGEN CORP(RGEN)77,80077,80009,16610,6151.70%+1,449
DEXCOM INC(DXCM)90,000100,000+10,0005,6526,7351.08%+1,083
SCYNEXIS INC0260,206+260,20601,0590.17%+1,059
EVOMMUNE INC(EVMN)075,000+75,00009970.16%+997
ABBOTT LABORATORIES010,000+10,00009070.15%+907
SATELLOS BIOSCIENCE INC(MSLE)387,769387,76902,1833,0150.48%+832
BRIDGEBIO PHARMA INC(BBIO)010,000+10,00007450.12%+745
LEGEND BIOTECH CORP(LEGN)015,000+15,00004330.07%+433
TENAX THERAPEUTICS INC(TENX)215,934265,934+50,0003,4533,8690.62%+417
SAVARA INC(SVRA)050,000+50,00003080.05%+308
INTELLIA THERAPEUTICS INC(NTLA)75,00075,00009621,2690.20%+308
ENCOMPASS HEALTH CORP(EHC)42,00042,00004,0634,2450.68%+183
ODDITY TECH LTD
SHS CL A
70,00070,00009371,0590.17%+123
TREVI THERAPEUTICS INC(TRVI)6,6606,6600791240.02%+45
GENMAB A/S(GMAB)50,00050,00001,3421,3740.22%+32
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)43,85343,85303923340.05%-58
GILEAD SCIENCES INC(GILD)20,00020,00002,7872,5270.40%-261
PELOTON INTERACTIVE INC(PTON)200,000100,000-100,0008585910.09%-267
ACADIA PHARM12,9670-12,9672890-289
BOSTON SCIENTIFIC CORP(BSX)60,00080,000+20,0003,7653,4140.55%-351
CORVUS PHARMACEUTICALS INC(CRVS)115,00080,000-35,0001,6821,1950.19%-487
ARBUTUS BIOPHARMA CORP(ABUS)125,0000-125,0005630-562
PHATHOM PHARMACEUTICALS INC(PHAT)249,390200,000-49,3902,7712,1700.35%-601
ANTERIS TECHNOLOGIES GLOBAL(AVR)150,0000-150,0008330-832
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)50,0000-50,0009320-932
UNITEDHEALTH GRP(UNH)3,8000-3,8001,0280-1,028
ABIVAX SA-ADR(ABVX)10,0000-10,0001,1140-1,113
CORCEPT THERA(CORT)30,0000-30,0001,2090-1,209
REVOLUTION MEDICINES INC(RVMD)15,0000-15,0001,4590-1,459
HIMS & HERS HEALTH INC(HIMS)75,0000-75,0001,5570-1,557
KENVUE INC ORD(KVUE)100,0000-100,0001,7240-1,724
ICON PLC(ICLR)16,0000-16,0001,7710-1,771
NATERA INC(NTRA)9,0000-9,0001,8000-1,800
SCYNEXIS INC(SCYX)2,081,6600-2,081,6601,9090-1,909
CENTENE CORP(CNC)70,0000-70,0002,2920-2,292
MEDTRONIC PLC(MDT)100,00070,000-30,0008,6655,4760.88%-3,189
VIR BIOTECHNOLOGY INC(VIR)950,000519,300-430,7008,5125,2920.85%-3,220
PERSPECTIVE THERAPEUTICS INC(CATX)6,049,9996,299,999+250,00025,22821,4833.44%-3,745
TEVA PHARMACEUTICAL INDS LTD(TEVA)450,100200,000-250,10013,5576,7761.09%-6,781
IMMUNIC INC(IMUX)6,699,4110-6,699,4117,4360-7,436
CONTEXT THERAPEUTICS INC(CNTX)4,998,2674,998,267013,0952,7690.44%-10,327
Page 1 of 1
Avidity Partners Management LP — 13F Holdings — Q2 2026 | TickerTrail